
7,000 steps a day could be enough to improve health, say researchers
The NHS recommends a brisk 10-minute walk every day. Many people aim to walk 10,000 steps, but struggle to achieve it. Now researchers have calculated that even 7,000 steps could be enough to protect health.
Scientists examined data from more than 160,000 adults and found that walking 7,000 steps a day was associated with a reduced risk of a number of serious health conditions and death.
Whereas previous studies have mainly examined the links between step count and heart health or overall death rates, this systematic review and meta analysis, published in the Lancet Public Health, sought to comprehensively examine how taking more steps per day could reduce the risk of a range of other health conditions as well.
Compared with those who walked 2,000 steps a day, the researchers found that achieving the 7,000 daily step target was linked to a 37% reduction in risk of dying from cancer, while the risk was 14% lower for type 2 diabetes, 38% for dementia, 22% depression and 28% for falls respectively. It was also associated with a 25% lower risk of cardiovascular disease and a 47% reduction in overall risk of dying.
Although step count does not measure the quality or intensity of exercise, the findings underscore the importance of being active. There is a 'return on investment' with every additional 1,000 steps taken and even 4,000 steps per day reduced the risk of disease, compared with very low activity levels, the researchers observed.
Although the risk continues to decrease above 7,000 steps, the rate at which it reduces that risk starts to slow. Melody Ding, professor of public health at the University of Sydney and lead author of the research, said that those who already walked 10,000 steps should not go back to 7,000, but that 7,000 was a more practical target for those who were currently inactive.
'Those who are currently active and achieving the 10,000 steps a day, keep up the good work – there is no need to modify your step counts. However, for those of us who are far from achieving the 10,000 targets, getting to 7,000 steps/day offers almost comparable health benefits for the outcomes we examined.'
Responding to the findings, Dr Daniel Bailey, reader in sedentary behaviour and health at Brunel University of London, said the research helped 'debunk the myth that 10,000 steps per day should be the target for optimal health.
'The real-world implications are that people can get health benefits just from small increases in physical activity, such as doing an extra 1,000 steps per day. To achieve the best reductions in risk, aiming for 5,000-7,000 per day can be recommended, which will be more achievable for many people than the unofficial target of 10,000 steps that has been around for many years.'
Dr Andrew Scott, senior lecturer in clinical exercise physiology at the University of Portsmouth, pointed out that not all activity was captured by step counts. 'The steps per day is useful when people's exercise is weight-bearing, however cycling, swimming and rowing are not well-represented by the steps-per-day model.'
June Davison, senior cardiac nurse at the British Heart Foundation, said: 'We know that regular walking is one of the easiest ways to help maintain a healthy lifestyle and reduce your risk of heart disease.
'Adults should aim to build up to a total of 150 minutes of moderate-intensity activity every week, but getting active isn't always easy. Incorporating activity snacks, such as walking while taking phone calls, or taking a brisk 10-minute walk during your lunch break, can all count to reduce your chances of developing heart disease.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
27 minutes ago
- The Independent
Unique blood test could catch cancer early
A new clinical trial, Enlighten, is assessing a blood test designed to detect 10 different types of cancer in their very early stages. Developed by Proteotype Diagnostics and led by the Southampton Clinical Trials Unit, the test identifies specific proteins in the blood that indicate the immune system's response to initial cancer signs. Unlike other tests focusing on abnormal DNA, Enlighten targets protein levels, which experts believe are more effective for detecting cancer at its earliest stages. The Modernised trial aims to recruit 1,000 patients across various solid tumour types, with 450 already participating, and is running at multiple hospital sites in the UK. Researchers emphasise that early cancer detection, facilitated by such tests, is crucial for improving treatment options and increasing successful outcomes for patients.


BBC News
28 minutes ago
- BBC News
Bird flu confirmed at commercial poultry farm near Tiverton
Bird flu has been confirmed at a farm in Devon, the Department for Environment, Food and Rural Affairs (Defra) has said the case had occurred at a commercial poultry business near Tiverton on Wednesday and that all birds at the site would be humanely culled. A 3km (1.9 mile) protection zone and 10km (6.2 mile) surveillance zone has been declared around the keeping poultry or other captive birds within the two zones must keep them housed and a record of all people who enter or leave the property, Defra said. It comes after a case of bird flu was confirmed in poultry near Minehead and Dulverton in Somerset on Scotland and Wales have been designated an avian influenza prevention zone (AIPZ) with mandatory biosecurity measures in place until further AIPZ measures apply to all bird keepers whether they have pet or commercial biosecurity is essential to protecting flocks from bird flu, Defra added.


BBC News
28 minutes ago
- BBC News
Sir David MacMillan: 'I'd bet my house' on treatment for Alzheimer's
A Nobel Prize-winning Scottish chemist has told the BBC he thinks drugs to treat Alzheimer's disease will be available within five University's Prof David MacMillan, who is originally from North Lanarkshire, said "phenomenal things" are happening within medical research into neurological diseases."I would bet my house that within five years that we have marketed drugs for Alzheimer's," Prof MacMillan told the BBC's Scotcast podcast."My father died of vascular dementia and my aunt had dementia. I think that's such a horrible way to go." The Scottish scientist was awarded the 2021 Nobel Prize in Chemistry alongside Prof Benjamin List after developing a new way of building molecules. Their work has led to developments in drugs for Alzheimer's, cancer and heart MacMillan, 57, said the award had made a massive impact on his life"On a Tuesday morning, I was a chemist that nobody, including half my pals, had been interested in talking to," he said."Then on the Wednesday, I was talking to like the New York Times and the Wall Street Journal."It was crazy - and I thought it would slow down but it just keeps on going."Prof MacMillan was awarded a half share of 10 million Norwegian krona (£842,611).He used it to set up The May and Billy MacMillan Foundation, named after his parents, where he funds Scottish students, providing educational opportunities to underprivileged young said education and learning was always good and gaining more experience was incredibly important. Passport to the world It is something he knows about from his own grew up in New Stevenston, near Bellshill, and gained his undergraduate degree in chemistry at the University of Glasgow before moving to the US for postgraduate studies."I realised that education is your passport to the world," he studying in California in the early 1990s, he moved to Harvard and the University of California at Berkeley before becoming a professor at Princeton in said working in the US had been great because its "research is the infrastructure that drives the health of the world".The possibilities of the people he was able to collaborate with had been "mind-boggling", he said. However, recent developments in US universities are causing concern, he Donald Trump and his Vice-President JD Vance have long railed against higher education institutions and they have been putting pressure on them over the first time in 25 years, Prof Macmillan's research group at Princeton has received no funding for the first seven months of the year from the US government. He said: "Americans still care about the Nobel Prize."If that could happen to somebody like me, it could happen to anybody."The scientist said that academics were now the resistance as they try to deal with the politics of the current US administration "without selling their soul".Prof MacMillan said the cuts were "quite sinister" because it seemed like a way to control universities and the narrative by deciding who they can hire. Higher education has become a hub for progressive thinking, which in his opinion, he said the Republicans don't like. "What they care the most about is retaining power," he said. Despite the pressure in the US, Prof MacMillan is not planning a return to Scotland just yet but he does regularly come back to see family - and some newfound friends. He told the podcast he had become good friends with a Scottish legend who phoned to congratulate him after he won the Nobel people would ignore a call that said 'No Caller ID' but he answered to find Sir Alex Ferguson on the other end of the professor, who was himself knighted in 2022, said he thought one of his friends had been joking with him by pretending to be Sir he recognised that the voice sounded too similar to the former Manchester United football manager. The two spoke about their common ground of growing up in Glasgow and the pair are now good friends who will be watching Manchester United play Chelsea together later in the year. Prof MacMillan not only sits next to Sir Alex at football games, the two will now feature together in the National Portrait Gallery of Scotland as the Scots chemist has had his portrait Scots scientist said he was "blown away by it".The painting by Christabel Blackburn depicts the chemist sitting in his office with a white lab coat in the corner. Prof MacMillan said it was actually a lab coat that he was "quite proud of" because it had been presented to him from his old school Bellshill Academy - which now sits in his office in Princeton University.